Cromolyn inhibits the secretion of inflammatory cytokines by human microglia (HMC3)
Abstract Cromolyn is a known mast cell stabilizer and is approved for treatment of asthma and for other allergic indications. Cromolyn, in a new redesigned dry powder formulation, is being tested in a pivotal clinical trial in combination with low dose ibuprofen to treat early Alzheimer’s Disease (A...
| Main Authors: | , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Nature Portfolio
2021-04-01
|
| Series: | Scientific Reports |
| Online Access: | https://doi.org/10.1038/s41598-021-85702-8 |
| _version_ | 1818742891993890816 |
|---|---|
| author | Yi-Jun Wang Alina Monteagudo Matthew A. Downey Philip G. Ashton-Rickardt David R. Elmaleh |
| author_facet | Yi-Jun Wang Alina Monteagudo Matthew A. Downey Philip G. Ashton-Rickardt David R. Elmaleh |
| author_sort | Yi-Jun Wang |
| collection | DOAJ |
| description | Abstract Cromolyn is a known mast cell stabilizer and is approved for treatment of asthma and for other allergic indications. Cromolyn, in a new redesigned dry powder formulation, is being tested in a pivotal clinical trial in combination with low dose ibuprofen to treat early Alzheimer’s Disease (AD) subjects. To better understand the mechanistic effect cromolyn has in slowing down or halting the neuroinflammatory response associated with AD progression, we tested the effect of cromolyn to dampen the inflammatory response in the human HMC3 microglia cell line. The direct effect of cromolyn on HMC3 microglia is on cytokines and chemokines production following their activation by the inflammatory cytokine TNF-α. Cromolyn and a new fluorinated analog dramatically reduced the secretion of a wide spectrum of inflammatory mediators, which included cytokines such as IL-1β, IL-6, IL-8 and IFN-γ, and chemokines such as CXCL10, CCL2, CCL3 and CCL4. These results bolster our understanding of how our cromolyn platform modulates toxic microglia behavior as a dynamic future treatment option for neurodegenerative disorders. |
| first_indexed | 2024-12-18T02:19:44Z |
| format | Article |
| id | doaj.art-12e89e9db6224c8982a7700a49b3f833 |
| institution | Directory Open Access Journal |
| issn | 2045-2322 |
| language | English |
| last_indexed | 2024-12-18T02:19:44Z |
| publishDate | 2021-04-01 |
| publisher | Nature Portfolio |
| record_format | Article |
| series | Scientific Reports |
| spelling | doaj.art-12e89e9db6224c8982a7700a49b3f8332022-12-21T21:24:16ZengNature PortfolioScientific Reports2045-23222021-04-0111111110.1038/s41598-021-85702-8Cromolyn inhibits the secretion of inflammatory cytokines by human microglia (HMC3)Yi-Jun Wang0Alina Monteagudo1Matthew A. Downey2Philip G. Ashton-Rickardt3David R. Elmaleh4AZTherapies Inc.AZTherapies Inc.AZTherapies Inc.AZTherapies Inc.AZTherapies Inc.Abstract Cromolyn is a known mast cell stabilizer and is approved for treatment of asthma and for other allergic indications. Cromolyn, in a new redesigned dry powder formulation, is being tested in a pivotal clinical trial in combination with low dose ibuprofen to treat early Alzheimer’s Disease (AD) subjects. To better understand the mechanistic effect cromolyn has in slowing down or halting the neuroinflammatory response associated with AD progression, we tested the effect of cromolyn to dampen the inflammatory response in the human HMC3 microglia cell line. The direct effect of cromolyn on HMC3 microglia is on cytokines and chemokines production following their activation by the inflammatory cytokine TNF-α. Cromolyn and a new fluorinated analog dramatically reduced the secretion of a wide spectrum of inflammatory mediators, which included cytokines such as IL-1β, IL-6, IL-8 and IFN-γ, and chemokines such as CXCL10, CCL2, CCL3 and CCL4. These results bolster our understanding of how our cromolyn platform modulates toxic microglia behavior as a dynamic future treatment option for neurodegenerative disorders.https://doi.org/10.1038/s41598-021-85702-8 |
| spellingShingle | Yi-Jun Wang Alina Monteagudo Matthew A. Downey Philip G. Ashton-Rickardt David R. Elmaleh Cromolyn inhibits the secretion of inflammatory cytokines by human microglia (HMC3) Scientific Reports |
| title | Cromolyn inhibits the secretion of inflammatory cytokines by human microglia (HMC3) |
| title_full | Cromolyn inhibits the secretion of inflammatory cytokines by human microglia (HMC3) |
| title_fullStr | Cromolyn inhibits the secretion of inflammatory cytokines by human microglia (HMC3) |
| title_full_unstemmed | Cromolyn inhibits the secretion of inflammatory cytokines by human microglia (HMC3) |
| title_short | Cromolyn inhibits the secretion of inflammatory cytokines by human microglia (HMC3) |
| title_sort | cromolyn inhibits the secretion of inflammatory cytokines by human microglia hmc3 |
| url | https://doi.org/10.1038/s41598-021-85702-8 |
| work_keys_str_mv | AT yijunwang cromolyninhibitsthesecretionofinflammatorycytokinesbyhumanmicrogliahmc3 AT alinamonteagudo cromolyninhibitsthesecretionofinflammatorycytokinesbyhumanmicrogliahmc3 AT matthewadowney cromolyninhibitsthesecretionofinflammatorycytokinesbyhumanmicrogliahmc3 AT philipgashtonrickardt cromolyninhibitsthesecretionofinflammatorycytokinesbyhumanmicrogliahmc3 AT davidrelmaleh cromolyninhibitsthesecretionofinflammatorycytokinesbyhumanmicrogliahmc3 |